ATE107283T1 - Herstellung von polymorphisch reinem terfenadine. - Google Patents

Herstellung von polymorphisch reinem terfenadine.

Info

Publication number
ATE107283T1
ATE107283T1 AT88106898T AT88106898T ATE107283T1 AT E107283 T1 ATE107283 T1 AT E107283T1 AT 88106898 T AT88106898 T AT 88106898T AT 88106898 T AT88106898 T AT 88106898T AT E107283 T1 ATE107283 T1 AT E107283T1
Authority
AT
Austria
Prior art keywords
production
polymorphically pure
terfenadine
pure terfenadine
polymorphically
Prior art date
Application number
AT88106898T
Other languages
English (en)
Inventor
Timothy G Fawcett
Christian T Goralski
David W Ziettlow
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8198929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE107283(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE107283T1 publication Critical patent/ATE107283T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88106898T 1988-04-29 1988-04-29 Herstellung von polymorphisch reinem terfenadine. ATE107283T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88106898A EP0339118B1 (de) 1988-04-29 1988-04-29 Herstellung von polymorphisch reinem Terfenadine

Publications (1)

Publication Number Publication Date
ATE107283T1 true ATE107283T1 (de) 1994-07-15

Family

ID=8198929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88106898T ATE107283T1 (de) 1988-04-29 1988-04-29 Herstellung von polymorphisch reinem terfenadine.

Country Status (8)

Country Link
US (1) US4742175A (de)
EP (1) EP0339118B1 (de)
AR (1) AR243612A1 (de)
AT (1) ATE107283T1 (de)
CA (1) CA1312610C (de)
DE (1) DE3850244T2 (de)
DK (1) DK173555B1 (de)
ES (1) ES2056851T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
IT1217837B (it) * 1988-06-17 1990-03-30 Lepetit Spa Procedimento per la preparazione del "alfa /4(1,1 dimetiletil)fenil/piperidinbutanolo"
ZA901360B (en) * 1989-02-28 1990-11-28 Merrell Dow Pharma Preparation of the low-melting polymorphic form of terfenadine
CA2015390A1 (en) * 1989-05-01 1990-11-01 Frederick J. Mccarty Process for the preparation of the high melting polymorphic of terfenadine
US5247092A (en) * 1989-12-29 1993-09-21 Erregierre Industria Chimica S.P.A. Preparation of the high-melting polymorph of terfenadine
FR2681861B1 (fr) * 1991-10-01 1995-06-09 Isochem Sa Procede de preparation d'une forme polymorphique de la terfenadine, a point de fusion eleve, d'une plus grande purete et produit obtenu.
US5347006A (en) * 1992-12-31 1994-09-13 Augusto Lavacchielli Method of preparing a polymorph of terfenadine
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
HU226559B1 (en) * 1993-06-24 2009-03-30 Amr Technology Process for the production of piperidine derivatives
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
EP1953142A1 (de) 1993-06-25 2008-08-06 Aventis Inc. Neuartige Zwischenprodukte zur Herstellung antihistaminischer 4-Diphenylmethyl-/Diphenylmethoxy-Piperidinderivate
IT1270829B (it) * 1993-09-17 1997-05-13 Recordati Chem Pharm Procedimento per la preparazione di polimorfo i della terfenadina con distribuzione granulometrica ottimale
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2449419C (en) * 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
ZA728544B (en) * 1972-01-28 1974-02-27 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine

Also Published As

Publication number Publication date
DK210888D0 (da) 1988-04-18
AR243612A1 (es) 1993-08-31
DE3850244T2 (de) 1994-10-06
EP0339118B1 (de) 1994-06-15
DE3850244D1 (de) 1994-07-21
ES2056851T3 (es) 1994-10-16
DK173555B1 (da) 2001-03-12
CA1312610C (en) 1993-01-12
US4742175A (en) 1988-05-03
EP0339118A1 (de) 1989-11-02
DK210888A (da) 1989-10-19

Similar Documents

Publication Publication Date Title
DE3850244D1 (de) Herstellung von polymorphisch reinem Terfenadine.
ATE72660T1 (de) Herstellung von zeolith-l.
DE3780933D1 (de) Herstellung von aminoalanen.
ATE131185T1 (de) Herstellung von peroxidhaltigen perfluorpolyethern.
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
DE3675169D1 (de) Herstellung von tabletten.
DE3667989D1 (de) Kontinuierliche herstellung von elastischen polyestern.
DE69018071D1 (de) Herstellung von peroxysäuren.
DE3882852D1 (de) Herstellung von diglyceriden.
DE3576504D1 (de) Herstellung von ethylenoxid.
DE3773470D1 (de) Herstellung von kupfer-berylliumlegierungen.
DE69116826D1 (de) Herstellung von Alkoxyalkansäuren
DE68923795D1 (de) Herstellung von alkylbenzolen.
ATE116961T1 (de) Herstellung von zitronensäure.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3766559D1 (de) Herstellung von kristallinem tribromstyrol.
DE69213447D1 (de) Herstellung von n-acylimidazolen
ATE74629T1 (de) Kontinuierliche herstellung von dialkansulfonylperoxiden.
DE68921340D1 (de) Herstellung von epoxinitraten.
DE3870723D1 (de) Herstellung von ascorbinsaeure-6-estern.
DE59405004D1 (de) Herstellung von 2-H-Heptafluorpropan
DE68910122D1 (de) Herstellung von wellpappe.
DE3875281D1 (de) Herstellung von pseudoiononen.
DE3884654D1 (de) Herstellung von chromogenischen Cryptahemispheranden.
DE3768168D1 (de) Selektive herstellung von cis-perhydroacenaphthen.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time